Evinature
Evinature53
About
What does Evinature do?
Evinature is a science-first nutraceutical company that develops and provides evidence-based natural remedies for gastrointestinal health, with a primary focus on Inflammatory Bowel Disease (IBD). Their flagship product, CurQD, combines botanical wisdom with clinical rigor and is integrated into numerous medical centers in the US. The company aims to bridge the gap between conventional medicine and integrative therapies, offering personalized, safe, and effective solutions.
What is Evinature's revenue?
StartupHub estimates Evinature's annual revenue at $3.5M (range $2.0M to $6.0M, 63% confidence), based on comparable companies in the sector.
What is Evinature's valuation?
StartupHub estimates Evinature's effective valuation at $10.5M (range $6.8M to $16.2M, 16% confidence), based on comparable companies in the sector.
How much funding has Evinature raised?
Evinature has raised a total of $3M in funding. The most recent round on record is Early Stage VC.
Where is Evinature headquartered?
Evinature is headquartered in Binyamina, Israel.
When was Evinature founded?
Evinature was founded in 2021.
What industry does Evinature operate in?
Evinature operates in HealthTech, Biotech, Nutraceuticals, Gut Health, Inflammatory Bowel Disease (IBD), Personalized Medicine.
How many employees does Evinature have?
Evinature has approximately 19 people on record.
No comments yet. Be the first to share your take.